Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening.

Napoleone A, Sebastian IR, De Marco F, Molin A, Hussein M, Kramer L, Jostock T, Kelly T, Borth N

Open source

DOI
10.1016/j.omta.2026.201678
Published
2026 Mar 12
Container
Molecular therapy. Advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omta.2026.201678,
  title = {Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening.},
  author = {Napoleone A and Sebastian IR and De Marco F and Molin A and Hussein M and Kramer L and Jostock T and Kelly T and Borth N},
  year = {2026},
  journal = {Molecular therapy. Advances},
  doi = {10.1016/j.omta.2026.201678},
  url = {https://doi.org/10.1016/j.omta.2026.201678}
}

RIS

TY  - JOUR
TI  - Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening.
AU  - Napoleone A
AU  - Sebastian IR
AU  - De Marco F
AU  - Molin A
AU  - Hussein M
AU  - Kramer L
AU  - Jostock T
AU  - Kelly T
AU  - Borth N
PY  - 2026
JO  - Molecular therapy. Advances
DO  - 10.1016/j.omta.2026.201678
UR  - https://doi.org/10.1016/j.omta.2026.201678
ER  - 

APA

A, N., IR, S., F, D. M., A, M., M, H., L, K., T, J., T, K., & N, B. (2026). Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening.. Molecular therapy. Advances. https://doi.org/10.1016/j.omta.2026.201678

Source records